BioSpace News Archive

City of Hope today announced the induction of Phil Fasano, a Fortune 100 business strategy expert, to its board of directors.

Verily, an Alphabet company, today announced a new Project Baseline initiative, the Baseline Health System Consortium, comprised of Verily, Duke University Health System, Vanderbilt University Medical Center, University of Mississippi Medical Center, Mayo Clinic, Regional Health in South Dakota and University of Pittsburgh.

Data to be presented underscore commitment to developing life-changing medicines in hematology/oncology for people with limited or no treatment options

The Company was informed that newsletter and emails were sent from a non-affiliated third party source.

Ra Medical alleges that the statements breached the non-disparagement provision of a prior settlement agreement to which Strata was expressly bound.

Avantor, Inc. announced that it has priced the initial public offering of 207,000,000 shares of its common stock at a price to the public of $14.00 per share and a concurrent public offering of 18,000,000 shares of its 6.250% Series A Mandatory Convertible Preferred Stock at a price to the public of $50.00 per share.

Six internationally-recognized scientists join Akrevia’s scientific advisory board to advance the development of potent, tumor-targeted immunotherapies

Designed by a team of usability experts, the new UI includes an updated look and feel with new fonts, button styles, and colors.

Partnership creates promise for improving the health of those living with this debilitating and costly disease

Additional follow-up from the completed Phase 1/2 Northstar (HGB-204) study of LentiGlobin in adolescents and adults with TDT